Jantar MantarHorse Peptide Nile, a striking bay horse born in Japan in 2018, has captured the attention of the racing world with a remarkable upset victory in the 2024 February StakesPeptide Nile Flows To Upset Victory In G1 February Stakes. This thoroughbred, sired by the prominent King Kamehameha and out of the mare Queen Olive, defied expectations as a 38-1 longshot to claim his first Group 1 title.Eleventh Pick Peptide Nile Upsets in Dirt G1 February Stakes Trained by Hidenori Take and owned by Kazuhiko Numakawa, Peptide Nile's performance in this prestigious JRA event marks a significant moment in his racing career.
Peptide Nile's pedigree boasts impressive lineage, with his sire, King Kamehameha, being a leading sire in Japan. This strong genetic background hints at the potential for exceptional performance on the track2025年4月5日—OverseasHorsesDetail Information, SimulcastHorsesDetail Information.. While the exact details of his early races leading up to the February Stakes are extensive, his race record indicates a developing talent. The horse's breeding farm is Kineusu Bokujo, and his birth date is April 24, 2018. As a bay horse, his physical characteristics are typical of many successful racehorses.
The 2024 February Stakes, held on February 18th, saw Peptide Nile deliver an astonishing performance that stunned many observers.February Stakes (G1) - Comments from runners' connections Despite being a lightly regarded contender, the horse raced prominently from the early stages, securing an outside stalking position under jockey Yusuke FujiokaTOP|Japan Horse Racing Tips-Umanity.jp - Peptide Nile. This tactical approach paid off handsomely as Peptide Nile surged forward to win by a comfortable margin, clinching his first G1 title and earning a berth in the Breeders' Cup. This victory was particularly notable as it was the JRA's opening Group 1 contest of the year, and Peptide Nile's win was a significant upset2024年2月20日—The Asian Bloodstock Review:Peptide Niledelivers latest Group 1 success for King Kamehameha..
Peptide Nile's racing record shows a horse with considerable grit and potentialPeptide Nile horse profile and form. Race Record, Pedigree, Form, Photo, results, future entries, jockeys, trainers, owners, breeders, and 300k + horse .... As of recent reports, he is an 8-year-old horse who has competed in races from 2024 onwards. His earnings have reached considerable heights, reflecting his success in high-stakes races. His previous runs and entries are meticulously tracked, providing valuable insights into his performance history.Eleventh Pick Peptide Nile Upsets in Dirt G1 February Stakes The horse's trainer, Hidenori Take, and owner, Kazuhiko Numakawa, have been instrumental in guiding his career.
The success of Peptide Nile underscores the strength of his sire, King Kamehameha, who has produced numerous stake winners and champions. The dam, Queen Olive, also contributes to his robust breeding. This strong pedigree suggests that Peptide Nile has the potential for continued success in elite racing.11th Pick Peptide Nile Earns Stunning Upset in February ... His victory in the February Stakes has positioned him as a horse to watch in upcoming major races, including potential attempts to defend his title in future editions of the February Stakes, aiming to become a true dirt king.Peptide Nile; Owner, Kazuhiko Numakawa ; Breeder, Kineusu Bokujo ; Records, 8-2-3-15 ; Earnings, 292.5M (JPY) ; Last Race, 7 Dec 2025 CHAMPIONS CUP G1.
Peptide Nile's journey to victory in the 2024 February Stakes is a testament to the unpredictable and thrilling nature of horse racing. From an 11th-pick longshot to a Group 1 champion, his performance has etched his name in racing history. With a powerful pedigree and a demonstrated ability to perform under pressure, Peptide Nile is poised to remain a significant figure in the racing scene, with fans eagerly anticipating his future performances.Peptide Nile Racehorse Profile, Stats, Form Guide ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.